Aytu BioScience

Aytu BioScience (NASDAQ: AYTU) is a growing specialty pharmaceutical company focused on commercializing novel products that address significant patient needs. The company markets Natesto (testosterone nasal gel, C III), ZolpiMist (zolpidem tartrate oral spray, CIV), and Tuzistra XR (codeine polistirex & chlorpheniramine polistirex, CIII) in the United States and plans to in-license or acquire additional novel products to complement the company's therapeutic portfolio.Outside the U.S., Aytu BioScience markets the company’s proprietary MiOXSYS system, a novel, point-of-care diagnostic system with the potential to become a standard of care as an aid in the diagnosis of male infertility. MiOXSYS is CE Marked, Health Canada approved, Australian TGA approved, and approved by Mexico's COFEPRAS.